Which Study When? Is Gadolinium-enhanced MR Imaging Safer than Iodine-enhanced CT? 1
2008; Radiological Society of North America; Volume: 249; Issue: 1 Linguagem: Inglês
10.1148/radiol.2491080075
ISSN1527-1315
Autores Tópico(s)Radioactive element chemistry and processing
ResumoHomeRadiologyVol. 249, No. 1 PreviousNext Reviews and CommentaryControversiesWhich Study When? Is Gadolinium-enhanced MR Imaging Safer than Iodine-enhanced CT?1Jeffrey C. WeinrebJeffrey C. WeinrebAuthor Affiliations1From the Department of Diagnostic Radiology, Yale University School of Medicine, 333 Cedar St, PO Box 208042, New Haven, CT 06520-8042. Received January 11, 2008; final version accepted July 7.Address correspondence to the author (e-mail: [email protected]).Jeffrey C. WeinrebPublished Online:Oct 1 2008https://doi.org/10.1148/radiol.2491080075MoreSectionsFull textPDF ToolsAdd to favoritesCiteTrack CitationsPermissionsReprints ShareShare onFacebookXLinked In References1 Elicker BM, Cypel YS, Weinreb JC. IV contrast administration for CT: a survey of practices for the screening and prevention of contrast nephropathy. AJR Am J Roentgenol 2006; 186: 1651–1658. Crossref, Medline, Google Scholar2 Investigation of the safety of MRI contrast medium Omniscan, May 29, 2006. Danish Medicines Agency Website. http://www.dkma.dkr/1024/visUKLSArtikel.asp?artikelID=8931. Accessed September 13, 2007. Google Scholar3 Grobner T. Gadolinium: a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol Dial Transplant 2006; 21: 1104–1108. [Published correction appears in Nephrol Dial Transplant 2006;21:1745.] Crossref, Medline, Google Scholar4 Food and Drug Administration Center for Drug Evaluation and Research. Public health advisory. Update on magnetic resonance imaging (MRI) contrast agents containing gadolinium and nephrogenic fibrosing dermopathy. http://www.fda.gov/cder/drug/advisory/gadolinium_agents20061222htm. Accessed July 18, 2006. Google Scholar5 Food and Drug Administration Center for Drug Evaluation and Research. Information for healthcare professionals: gadolinium-based contrast agents for magnetic resonance imaging. http://www.fda.gov/cder/drug/InfoSheets/HCP/gcca_200705.htm. Accessed June 29, 2007. Google Scholar6 Kanal E, Barkovich AJ, Bell C, et al. ACR guidance document for safe MR practices: 2007. AJR Am J Roentgenol 2007; 188: 1447–1474. Crossref, Medline, Google Scholar7 Updated ACR screening recommendations on gadolinium-based MR contrast agents, renal disease patients, and nephrogenic systemic fibrosis (NSF). http://www.acr.org/SecondaryMainMenuCategories/quality_safety/MRSafety/recommendations_gadolinium-based.aspx. Accessed August 6, 2007. Google Scholar8 Kanal E, Broome DR, Martin DR, Thomsen HS. Response to the FDA's May 23, 2007, nephrogenic systemic fibrosis update. Radiology 2008; 246: 11–14. Link, Google Scholar9 Parfrey PS, Griffiths SM, Barrett BJ, et al. Contrast-material induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. N Engl J Med 1989; 320: 143–149. Crossref, Medline, Google Scholar10 Rihal CS, Textor SC, Grill DE, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 2002; 105: 2259–2264. Crossref, Medline, Google Scholar11 Barrett BJ. Contrast nephrotoxicity. J Am Soc Nephrol 1994; 5: 125–137. Crossref, Medline, Google Scholar12 Brezis M, Epstein FH. A closer look at radiocontrast-induced nephropathy [editorial]. N Engl J Med 1989; 320: 179–181. Crossref, Medline, Google Scholar13 Gruberg L, Mintz GS, Mehran R, et al. the prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. J Am Coll Cardiol 2000; 36: 1542–1548. Crossref, Medline, Google Scholar14 Tepel M, van der Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 2000; 343: 180–184. Crossref, Medline, Google Scholar15 Rao QA, Newhouse JH. Risk of nephropathy after intravenous administration of contrast material: a critical literature analysis. Radiology 2006; 239: 392–397. Link, Google Scholar16 Becker J, Thomson H. Renal safety of gadolinium-based contrast agent for ionizing radiation imaging [letter]. Radiology 2006; 240: 301–302. Link, Google Scholar17 Rofsky NM, Weinreb JC, Bosniak MA. Renal lesion characterization with gadolinium-enhanced MR imaging: efficacy and safety in patients with renal insufficiency. Radiology 1991; 180: 85–89. Link, Google Scholar18 Haustein J, Niendorf HP, Krestin G, et al. Renal tolerance of gadolinium-DTPA dimeglumine in patients with chronic renal failure. Invest Radiol 1992; 27: 153–156. Crossref, Medline, Google Scholar19 Niendorf HP, Alhassan A, Geens VR, Clauss W. Safety review of gadopentetate dimeglumine: extended clinical experience after more than five million applications. Invest Radiol 1994; 29(suppl 2): S179–S182. Crossref, Medline, Google Scholar20 Prince MR, Arnoldus C, Frisoli JA. Nephrotoxicity of high dose gadolinium compared with iodinated contrast. J Magn Reson Imaging 1996; 6: 162–166. Crossref, Medline, Google Scholar21 Zhang HL, Ersoy H, Prince MR. Effects of gadopentetate dimeglumine and gadodi-amide on serum calcium, magnesium, and creatinine measurements. J Magn Reson Imaging 2006; 23: 383–387. Crossref, Medline, Google Scholar22 Spinosa DJ, Kaufmann JA, Hartwell GD. Gadolinium chelates in angiography and interventional radiology: a useful alternative to iodinated contrast media for angiography. Radiology 2002; 223: 319–325. Link, Google Scholar23 Remy-Jardin M, Dequiedt P, Ertzbischoff O, et al. Safety and effectiveness of gadolinium-enhanced multi-detector row spiral CT angiography of the chest: preliminary results in 37 patients with contraindications to iodinated contrast agents. Radiology 2005; 235: 819–826. Link, Google Scholar24 Thomsen HS. Gadolinium-based contrast media may be nephrotoxic even at approved doses. Eur Radiol 2004; 14: 1654–1656. Crossref, Medline, Google Scholar25 Thomsen HS. Guidelines for contrast media form the European Society of Urogenital Radiology. AJR Am J Roentgenol 2003; 181: 1463–1471. Crossref, Medline, Google Scholar26 Elmståhl B, Nyman U, Leander P, Chai CM, Frennby B, Almén T. Gadolinium contrast media are more nephrotoxic than a low osmolar iodine medium employing doses with equal x-ray attenuation in renal arteriography: an experimental study in pigs. Acad Radiol 2004; 11: 1219–1228. Crossref, Medline, Google Scholar27 Gemery J, Idelson B, Reid S, et al. Acute renal failure after arteriography with a gadolinium-based contrast agent. AJR Am J Roentgenol 1998; 171: 1277–1278. Crossref, Medline, Google Scholar28 Nyman U, Elmstahl B, Leander P, Nilsson M, Golman K, Almen T. Are gadolinium-base contrast media really safer than iodinated media for digital subtraction angiography in patients with azotemia? Radiology 2002; 223: 311–318. Link, Google Scholar29 Sam AD 2nd, Morasch MD, Collins J, Song G, Chen R, Pereles FS. Safety of gadolinium contrast angiography in patients with chronic renal insufficiency. J Vasc Surg 2003; 38: 313–318. Crossref, Medline, Google Scholar30 Erley CM, Bader BD, Berger ED, et al. Gadolinium-based contrast media compared with iodinated media for digital subtraction angiogrpahy in azotmeic patients. Nephrol Dial Transplant 2004; 19: 2526–2531. Crossref, Medline, Google Scholar31 Cowper SE, Robin HS, Steinberg SM, Su LD, Gupta S, LeBoit PE. Scleromyxo-edema-like cutaneous diseases in renal dialysis patients. Lancet 2000; 356: 1000–1001. Crossref, Medline, Google Scholar32 Penfield JG, Reilly RF Jr. What nephrologists need to know about gadolinium. Nat Clin Pract Nephrol 2007; 3: 654–688. Crossref, Medline, Google Scholar33 Broome DR, Girguis MS, Baron PW, Cottrell AC, Kjellin I, Kirk GA. Gadodi-amide-associated nephrogenic systemic fibrosis: why radiologists should be concerned. AJR Am J Roentgenol 2007; 188: 586–592. Crossref, Medline, Google Scholar34 Cowper SE, Boyer PJ. Nephrogenic systemic fibrosis: an update. Curr Rheumatol Rep 2006; 8: 151–157. Crossref, Medline, Google Scholar35 Cowper SE. Nephrogenic fibrosing dermopathy (NFD/NSF Web site) 2001–2007. http://www.icnfdr.org/. Accessed January 7, 2008. Google Scholar36 Deo A, Fogel M, Cowper SE. Nephrogenic systemic fibrosis: a population study examining the relationship of disease development to gadolinium exposure. Clin J Am Soc Nephrol 2007; 2: 264–267. Crossref, Medline, Google Scholar37 Sadowski EA, Bennett LK, Chan MR, et al. Nephrogenic systemic fibrosis: risk factors and incidence estimation. Radiology 2007; 243: 148–157. Link, Google Scholar38 Saab G, Abu-Alfa A, Sadowski EA, Djamali A. Are patients with moderate renal failure at risk for developing nephrogenic systemic fibrosis? [letter]. Radiology 2007; 244: 930–932. Link, Google Scholar39 Amis ES, Butler PF, Applegate KE, et al. American College of Radiology white paper on radiation dose in medicine. J Am Coll Radiol 2007; 4: 272–284. Crossref, Medline, Google Scholar40 Lee CI, Haims AH, Monico EP, Brink JP, Forman HP. Diagnostic CT scans: assessment of patient, physician, and radiologist awareness of radiation dose and possible risks. Radiology 2004; 231: 393–398. Link, Google Scholar41 Siegel MJ, Schmidt B, Bradley D, Suess C, Hildebolt C. Radiation dose and image quality in pediatric CT: effect of technical factors and phantom size and shape. Radiology 2004; 233: 515–522. Link, Google Scholar42 Chaljub G, Kramer LA, Johnson RF 3rd, Johnson RF Jr, Singh H, Crow WN. Projectile cylinder accidents resulting from the presence of ferromagnetic nitrous oxide or oxygen tanks in the MR suite. AJR Am J Roentgenol 2001; 177: 27–30. Crossref, Medline, Google Scholar43 Shellock FG, Crues JV. MR procedures: biologic effects, safety, and patient care. Radiology 2004; 232: 635–652. Link, Google Scholar44 Collidge TA, Thomson PC, Mark PB, et al. Gadolinium-enhanced MR imaging and nephrogenic systemic fibrosis: retrospective study of a renal replacement therapy cohort. Radiology 2007; 245: 168–175. Link, Google Scholar45 Bellin MF, Jakobsen JA, Tomassin I, et al. Contrast medium extravasation injury: guidelines for prevention and management. Eur Radiol 2002; 12: 2807–2812. Crossref, Medline, Google Scholar46 Cohan RH, Ellis JH, Garner WL. Extravasation of radiographic contrast material: recognition, prevention, and treatment. Radiology 1996; 200: 593–604. Link, Google Scholar47 Cohan RH, Bullard MA, Ellis JH, et al. Local reactions after injection of iodinated contrast material: detection, management, and outcome. Acad Radiol 1997; 4: 711–718. Crossref, Medline, Google Scholar48 Sistrom CL, Gay SB, Peffly L. Extravasation of iopamidol and iohexol during contrast-enhanced CT: report of 28 cases. Radiology 1991; 180: 707–710. Link, Google Scholar49 Cochran ST, Bomyea K, Sayre JW. Trends in adverse events after IV administration of contrast media. AJR Am J Roentgenol 2001; 176: 1385–1388. Crossref, Medline, Google Scholar50 Jacobs JE, Birnbaum BA, Langlotz CP. Contrast media reactions and extravasation: relationship to intravenous injection rates. Radiology 1998; 209: 411–416. Link, Google Scholar51 Federle MP, Chang PJ, Confer S, Ozgun B. Frequency and effects of extravasation of ionic and nonionic CT contrast media during rapid bolus injection. Radiology 1998; 206: 637–640. Link, Google Scholar52 Runge VM, Dickey KM, Williams NM, Peng X. Local tissue toxicity in response to extravascular extravasation of magnetic resonance contrast media. Invest Radiol 2002; 37: 393–398. Crossref, Medline, Google Scholar53 Morcos SK, Thomsen HS. Adverse reactions to iodinated contrast media. Eur Radiol 2001; 11: 1267–1275. Crossref, Medline, Google Scholar54 American College of Radiology Committee on Drugs and Contrast Media. Manual on contrast media. 5th ed. Reston, Va: American College of Radiology, 2004. Google Scholar55 Dillman JR, Ellis JH, Cohan RH, Strouse PJ, Jan SC. Allergic-like breakthrough reactions to gadolinium contrast agents after corticosteroid and antihistamine premedication. AJR Am J Roentgenol 2008; 190: 187–190. Crossref, Medline, Google Scholar56 Dillman JR, Strouse PJ, Ellis JH, Cohan RH, Jan SC. Incidence and severity of acute allergic-like reactions to IV nonionic iodinated contrast material in children. AJR Am J Roentgenol 2007; 188: 1643–1647. Crossref, Medline, Google Scholar57 Murphy KJ, Brunberg JA, Cohan RH. Adverse reactions to gadolinium contrast media: a review of 36 cases. AJR Am J Roentgenol 1996; 167: 847–849. Crossref, Medline, Google Scholar58 Murphy KP, Szopinski KT, Cohan RH, Mermillod B, Ellis JH. Occurrence of adverse reactions to gadolinium-based contrast material and management of patients at increased risk: a survey of the American Society of Neuroradiology Fellowship Directors. Acad Radiol 1999; 6: 656–664. Crossref, Medline, Google Scholar59 Li A, Wong CS, Wong MK, Lee CM, Au Yeung MC. Acute adverse reactions to magnetic resonance contrast media: gadolinium chelates. Br J Radiol 2006; 79: 368–337. Crossref, Medline, Google Scholar60 Jordan RM, Mintz RD. Fatal reaction to gadopentetate dimeglumine. AJR Am J Roentgenol 1995; 164: 743–744. Crossref, Medline, Google Scholar61 Mortelé KJ, Oliva MR, Ondatequi S, Ros PR, Silverman SG. Universal use of nonionic iodinated contrast medium for CT: evaluation of safety in a large urban teaching hospital. AJR Am J Roentgenol 2005; 184: 31–34. Crossref, Medline, Google Scholar62 Lin SP, Brown JJ. MR contrast agents: physical and pharmacologic basics. J Magn Reson Imaging 2007; 25: 884–899. Crossref, Medline, Google Scholar63 Patel SJ, Reede DL, Katz DS, Subramaniam R, Amorosa JK. Imaging the pregnant patient for nonobstetric conditions: algorithms and radiation dose considerations. RadioGraphics 2007; 27: 1705–1722. Link, Google ScholarArticle HistoryPublished in print: 2008 FiguresReferencesRelatedDetailsCited ByAdvanced Neuroimaging With Photon-Counting Detector CTFrederikAbel, TilmanSchubert, SebastianWinklhofer9 May 2023 | Investigative Radiology, Vol. 58, No. 7Thoracic calcifications on magnetic resonance imaging: correlations with computed tomographyJuliana FischmanZampieri, Gabriel SartoriPacini, MatheusZanon, Stephan Philip LeonhardtAltmayer, GuilhermeWatte, MarceloBarros, EvandraDurayski, Gustavo de Souza PortesMeirelles, Marcos DuarteGuimarães, EdsonMarchiori, Arthur SoaresSouza Junior, BrunoHochhegger2019 | Jornal Brasileiro de Pneumologia, Vol. 45, No. 4Head, Neck, and Orofacial InfectionsMatthew E.Lawler, ZacharyPeacock2016Cardiovascular PET/MRIRichardLaForest, Pamela K.Woodard, Robert J.Gropler2016 | Cardiology Clinics, Vol. 34, No. 1Risks to the fetus from diagnostic imaging during pregnancy: review and proposal of a clinical protocolMafaldaGomes, AlexandraMatias, FilipeMacedo2015 | Pediatric Radiology, Vol. 45, No. 13Novel functional magnetic resonance imaging biomarkers for assessing response to therapy in hepatocellular carcinomaZ.Yuan, W.-T.Li, X.-D.Ye, H.-Y.Zhu, W.-J.Peng2014 | Clinical and Translational Oncology, Vol. 16, No. 7Incidence of contrast medium extravasation for CT and MRI in a large academic medical centre: A report on 502,391 injectionsK.Shaqdan, S.Aran, J.Thrall, H.Abujudeh2014 | Clinical Radiology, Vol. 69, No. 12Utility of gadolinium-enhanced MR urography in detection of bladder carcinomaBlake D.Niederhauser, AkiraKawashima, Bernard F.King, NaokiTakahashi2013 | European Journal of Radiology, Vol. 82, No. 3Prophylactic 0.9% saline hydration inhibited high-dose gadodiamide-induced nephropathy in ratsC-CChien, M-JSheu, C-CChu, Y-MSun, W-CKan, H-YWang, J-CHwang, J-JWang2012 | Human & Experimental Toxicology, Vol. 31, No. 11Is administration of gadolinium‐based contrast media to pregnant women and small children justified?Pia C.Sundgren, PeterLeander16 September 2011 | Journal of Magnetic Resonance Imaging, Vol. 34, No. 4Venous Embolization of the LiverRichard K. G.Do, BachirTaouli2011Breast ImagingColin J.Wells, Nanette D.DeBruhl2011Youmans Neurological SurgeryAlessandroOlivi, MohamadBydon, Shaan M.Raza2011Efficacy and safety of lanthanoids as X-ray contrast agentsHubertusPietsch, GregorJost, ThomasFrenzel, MarianRaschke, JakobWalter, HeikoSchirmer, JoachimHütter, Martin A.Sieber2011 | European Journal of Radiology, Vol. 80, No. 2Nephrogenic Systemic Fibrosis and Gadolinium-Based Contrast AgentsAli K.Abu-Alfa2011 | Advances in Chronic Kidney Disease, Vol. 18, No. 3Evaluation of gadolinium‐enhanced T1‐weighted magnetic resonance imaging in the preoperative assessment of local staging in rectal cancerS.‐Y.Jao, B.‐Y.Yang, H.‐H.Weng, C.‐H.Yeh, L.‐W.Lee22 June 2009 | Colorectal Disease, Vol. 12, No. 11Effect of Intravascular Iodinated Contrast Media on Natural Course of End-Stage Renal Disease Progression in Hemodialysis Patients: A Prospective StudyRadimJanousek, AntoninKrajina, Jan H.Peregrin, SylvieDusilova-Sulkova, OndrejRenc, JanHajek, KamilDvorak, PetrFixa, EvaCermakova2010 | CardioVascular and Interventional Radiology, Vol. 33, No. 1Gadolinium Enhanced Magnetic Resonance Urography for Upper Urinary Tract MalignancyNaokiTakahashi, James F.Glockner, Robert P.Hartman, Bernard F.King, Bradley C.Leibovich, David W.Stanley, Patrick D.Fitz-Gibbon, AkiraKawashima2010 | Journal of Urology, Vol. 183, No. 4Screening Patients to Assess Renal Function Before Administering Gadolinium Chelates: Assessment of the Choyke QuestionnaireBrena F.Sena, Julia P.Stern, Pari V.Pandharipande, BarbaraKlemm, JulieBulman, IvanPedrosa, Neil M.Rofsky2010 | American Journal of Roentgenology, Vol. 195, No. 2Gadolinium‐based contrast agents and nephrogenic systemic fibrosis: Why did it happen and what have we learned?Jeffrey C.Weinreb, Ali K.Abu‐Alfa24 November 2009 | Journal of Magnetic Resonance Imaging, Vol. 30, No. 6May I Pl Mk a Requ for Rad to Stop Using Abr?Mervyn D. Cohen, , and 1 August 2009 | Radiology, Vol. 252, No. 2Current status of contrast-induced nephropathy and nephrogenic systemic fibrosis in childrenMusturayKarcaaltincaba, BernaOguz, MithatHaliloglu2009 | Pediatric Radiology, Vol. 39, No. S3Nephrogenic Systemic Fibrosis and Management of High-risk PatientsErsanAltun, Richard C.Semelka, CeylanCakit2009 | Academic Radiology, Vol. 16, No. 7Dynamic Contrast-Enhanced MR Imaging of the Liver: Current Status and Future DirectionsRichard Kinh GianDo, HenryRusinek, BachirTaouli2009 | Magnetic Resonance Imaging Clinics of North America, Vol. 17, No. 2Angiografía con contraste por resonancia magnética en las cardiopatías congénitasC.Marín Rodríguez, E. MarotoÁlvaro, M.L.Sánchez Alegre, Y. RuizMartín, J. DelgadoCarrasco2009 | Radiología, Vol. 51, No. 3Recommended Articles Notice of Withdrawal: MR Imaging and Gadolinium: Reassessing the Risk of Nephrogenic Systemic Fibrosis in Patients with Severe Renal DiseaseRadiology2018Volume: 286Issue: 1Imaging of Neurologic Conditions in Pregnant PatientsRadioGraphics2016Volume: 36Issue: 7pp. 2102-2122Effect of Intravenous Administration of Contrast Media on Serum Creatinine Levels in NeonatesRadiology2017Volume: 284Issue: 2pp. 530-540Use of Intravenous Gadolinium-based Contrast Media in Patients with Kidney Disease and the Risk of Nephrogenic Systemic Fibrosis: Radiology In TrainingRadiology2021Volume: 300Issue: 2pp. 279-284Hemodynamic Responses of the Placenta and Brain to Maternal Hyperoxia in Fetuses with Congenital Heart Disease by Using Blood Oxygen–Level Dependent MRIRadiology2019Volume: 294Issue: 1pp. 141-148See More RSNA Education Exhibits Safe Use Of Contrast Media In Breast Imaging; A Practical GuideDigital Posters2021From Head To Toe: Acute Presentations Of The Pregnant And Postpartum PatientDigital Posters2021Pitfalls Of Pregnancy: An Organ-system Review Of Non-obstetric Complications And Emergencies In The Pregnant PatientDigital Posters2021 RSNA Case Collection Acute appendicitis in pregnancyRSNA Case Collection2020Obstructing ureterovesical junction calculus in pregnancyRSNA Case Collection2020Acute PyelonephritisRSNA Case Collection2020 Vol. 249, No. 1 Metrics Altmetric Score PDF download
Referência(s)